www.prosenex.com

Cart: 0
items 
Dynamic Neuroscreening Device (DND)
The Dynamic Neuroscreening Device (DND) is nonnon-invasive and is used to detect peripheral neuropathy in patients with diabetes or at risk for diabetes who have yet to exhibit any clinical symptoms and can also establish a patient baseline for future screening. The DND screens for the presence of neuropathy through the use of objective temperature and vibration discrimination testing.
PROSENEX Specializes in Objective Screening for Peripheral Neuropathy


**Now in Partnership withTreVia Digital Health


"Bronze Winner in 2016 worldwide Medical Design Excellence Awards- MDEA"

"Finalist in 2016 T1D/M2D2 Global Diabetes Innovation Challenge"

Medical Necessity

Peripheral neuropathy is one of the major causes of sensation loss and significantly increases risk of feet ulceration with potential limb loss.

Objective Screening

Uniform patient screening for peripheral fiber neuropathy by graded temperature and vibration discrimination stimuli.

Benefits

The device may significantly improve patient compliance with medical advice by providing objective numerical data of the sensitivity status.